Biokimia Blok Neoplasia
Biokimia Blok Neoplasia
Harliansyah, Ph.D
YARSI University
Department of Biochemistry
harliansyah.hanif @ yarsi.ac.id
1
2
3
4
Cancer Pathogenesis
5
Cellular Basis of Cancer
Cancer is a collection of diseases
characterized by abnormal and
uncontrolled growth
7
1fertilizedegg
50x1012
1016celldivisions/lifetime
Transit
Renewing
Proliferating
Exiting 9
Cancer:disruptionof
cellularequilibrium
Invasion - direct
migration and
penetration into
neighboring tissues
12
Malignant versus Benign Tumors
Benign tumors
generally do not
spread by
invasion or
metastasis
Malignant
tumors are
capable of
spreading by
invasion and
metastasis
13
What causes Cancer?
Cancer is caused by
alterations or mutations in
the genetic code
Can be induced in somatic
cells by:
Carcinogenic
chemicals
Radiation
Some viruses
Heredity - 5%
14
Oncogenes
Cellcycle
Apoptosis TumorSuppressor
Angiogenesis Inv.andMets
15
HanahanandWeinberg,Cell100:57,2000
What is the molecular basis of
cancer?
Cancer is a genetic disease.
Mutations in genes result in
altered proteins
During cell division
External agents
Random event
Most cancers result from
mutations in somatic cells
Some cancers are caused by
mutations in germline cells
16
Theories of cancer genesis
Standard Dogma
Proto-oncogenes (Ras melanoma)
Tumor suppressor genes (p53
various cancers)
Modified Dogma
Mutation in a DNA repair gene
leads to the accumulation of
unrepaired mutations (xeroderma
pigmentosum)
Early-Instability Theory
Master genes required for
adequate cell reproduction are
disabled, resulting in aneuploidy
(Philadelphia chromosome)
17
CANCER AND GENETICS
Cancer: genome disease
Causes of genomic changes
Effects of genomic changes
Revolution in cancer treatment: Smart Bullets Period
18
CANCER: GENOME DISEASE
Loss of DNA
Gain of DNA
Changes in nucleotides
Epigenetic effects
19
Signs for Genomic Changes
in Cancer
Changes in chromosome numbers
- Aneuploidy
Chromosomal changes
- Increase in DNA copy number -15
different region
- Loss in chromosomal -200.000 regions
Micro changes
- Microsatellite changes
Mikrosatellite - 100.000
- Nucleotide changes
20
21
Chromosomal changes in the genome of cancer
cells: tip of the iceberg
Reciprocal Ring
Deletion Duplication
translocation Chromosome
22
http://www.tokyo-med.ac.jp/genet/cai-e.htm
Nucleotide changes in the genome of cancer
cells: unseen site of the iceberg
Nucleotide Nucleotide Nucleotide
Deletions Insertions Substitutions
23
http://www.tokyo-med.ac.jp/genet/cai-e.htm
DNA Loss in cancer cells
24
DNA Loss in cancer cells: beyond coincidence ...
Early Brain Tumor Advance Brain Tumor
(Astrocytoma Stage II) Glioblastoma Multiform (Stage IV)
25
Chromosomal loss:
Mostly, it is a sign
for the loss of a
tumor suppressor
gene
CDKN2
locus
PTEN
locus
RB1
locus
???
locus
p53
locus
26
Cancer: Genome Disease
Epigenetic effects
27
Genetic and Epigenetic Silencing of Tumor Suppressor Genes
Plass - 2002 28
THE CAUSES OF GENOMIC CHANGES IN CANCER
UV
Rearrangements
Point mutations (translocation, deletions,
amplifications)
Alters DNA of genes controlling cell proliferation.
(Proliferation becomes abnormal)
Cancer cell
29
THE CAUSES OF GENOMIC CHANGES IN CANCER:
Somatic Changes
Hasar Hasar
Kanser Riski areti
Etken Tr Etkeni
30
THE CAUSES OF GENOMIC CHANGES IN CANCER:
Hereditary Predisposition
Genes Disease Function Inheretance Cancer Risk
FA Genes F-A DNA Damage respose ? OR Lsemi
XP Genes NER Type
X-P OR Skin Ca.
DNA Repair
BLM Bloom DNA Helicase ? OR Various cancers
WRN Werner DNA Helicase ? OR Sarcoma
Rothmund-
RECQ4 Thomson
DNA Helicase OR Sarcoma
OD Colon,
MLH1, MSH2, MMR Endometrium Ca.
PMS1, PMS2 DNA Repair
OR Lsemi, NF1
OD Breast, Ovary,
BRCA1, BRCA2 DNA Repair Prostate, Pancreas
Ca
OR Lymphoma,
A-T Leukemia
ATM DNA Damage sense ?
OD Breast Ca. ?
31
p53 Li-Fraumeni DNA Damage sense OD Various cancers
CANCER AND
GENETICS
Approximately 90-95% of all cancers
are sporadic.
32
GENES PLAYING ROLE IN
CANCER DEVELOPMENT
Oncogenes
Tumor suppressor genes
DNA repair genes
33
What are the genes responsible for tumorigenic
cell growth?
Normal
Proto-oncogenes + Cell growth
and
Tumor suppressor genes
- proliferation
Cancer
Mutated or activated ++
oncogenes Malignant
transformation
Loss or mutation of
Tumor suppressor genes
34
ONCOGENES
36
Functions of Cellular Proto-Oncogenes
4. Nuclear
Proteins:
Transcription
3. Cytoplasmic Factors
Signal Transduction
Proteins
5. Cell Growth
Genes
37
A generic signalling
pathway
38
Oncogenes
proto-oncogene = ras
Oncogene = mutated
ras
Always activated
Always stimulating
proliferation
39
Amino acid substitutions in Ras family proteins
(inactivates GTPase)
amino acid position
41
CHROMOSOMAL REARRANGEMENTS OR TRANSLOCATIONS
Neoplasm Translocation Proto-oncogene
1
c-myc is translocated to the IgG locus, which results in its activated expression
2
bcr-abl fusion protein is produced, which results in a constitutively active abl kinase
42
GENE AMPLIFICATION
Oncogene Amplification Source of tumor
43
Oncogenes are usually dominant
(gain of function)
44
The result:
Overproduction of growth factors
Flooding of the cell with
replication signals
Uncontrolled stimulation in the
intermediary pathways
Cell growth by elevated levels of
transcription factors
45
Tumor suppressor genes
Normal function - inhibit cell
proliferation
Absence/inactivation of
inhibitor --> cancer
Both gene copies must be
defective
46
KNUDSON TWO HIT HYPOTHESIS IN FAMILIAL CASES
Familial RB (%30)
RB rb
Normal cells
RB rb RB rb
LOH Inactivation of a tumor suppressor
gene requires two mutations, inherited
mutation and somatic mutation.
47
Tumor cells Normal cells
KNUDSON TWO HIT HYPOTHESIS IN SPORADIC CASES
Normal RB RB
Cells
RB RB RB
LOH
Inactivation of a tumor
suppressor gene
RB requires two somatic
Tumor cells mutations.
Mutation
48
TUMOR SUPPRESSOR GENES
Disorders in which gene is affected
Daugther cell
Mitosis Gateway
Growth
Factors
S
CELL CYCLE
DNA replication
Cell cycle
inhibitors
Control Point
50
Rb gene
Rb protein controls cell cycle moving past G1 checkpoint
Rb protein binds regulatory transcription factor E2F
E2F required for synthesis of replication enzymes
E2F - Rb bound = no transcription/replication
Growth factor --> Ras pathway
--> G1Cdk-cyclin synthesized
Active G1 Cdk-cyclin kinase phosphorylates Rb
Phosphorylated Rb cannot bind E2F --> S phase
Disruption/deletion of Rb gene
Inactivation of Rb protein
--> uncontrolled cell proliferation --> cancer
51
p53
Phosphyorylated p53 activates transcription of
p21 gene
p21 Cdk inhibitor (binds Cdk-cyclin complex -->
inhibits kinase activity)
Cell cycle arrested to allow
DNA to be repaired
If damage cannot be repaired
--> cell death (apoptosis)
52
DNA REPAIR GENES
i.e.Breastcancersusceptibilitygenes(BRCA1andBRCA2)
Hereditarynonpolyposiscoloncancersusceptibilitygenes
(MSH2, MLH1, PMS1, PMS2) have DNA repair functions.
Their mutation will cause tumorigenesis.
53
Molecular
mechanisms of
DNA double
strand break BRCA1/2
repair
55
Tumor Progression
Multiple
Cellular
mutations lead to colon
cancer
Genetic changes --> tumor
changes
56
Revolution in cancer treatment:
Smart Bullets Period
57
Summary of 30 years of research (1971-2001)
58
Hanahan & Weinberg 2000
HERCEPTIN
Bilimsel Aratrmalarn
ERCEPTNKanserle Savaa Katks
STI-571
59
Translocation and Bcr-Abl fusion in CML
60
STI571againstBcrAbl
61
Smart bullet STI-571 lockes itself to the target molecule
STI-571
62
Thousands of Targets
?
? ? ?
?
?
? ?
HERCEPTIN
?
? ?
STI-571
? ?
?
? ?
?
? 63
MOLECULAR BIOLOGY & INFORMATICS
Biyoinformatik
~3.000.000.000 bp
DNA
~30.000 genes
~300.000 protein
~3.000.000 interaction 64
1 human cell
65